Literature DB >> 28591534

The Enigma of Regional Lymph Nodes in Melanoma.

Daniel Coit1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28591534     DOI： 10.1056/NEJMe1704290

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

1.  Has the melanoma information tsunami become a maelstrom?

Authors:  John F Thompson; Alexander M Menzies
Journal:  Melanoma Manag       Date:  2017-09-14

Review 2.  Sentinel Lymph Node Biopsy and Completion Lymph Node Dissection for Melanoma.

Authors:  Sabran J Masoud; Jennifer A Perone; Norma E Farrow; Paul J Mosca; Douglas S Tyler; Georgia M Beasley
Journal:  Curr Treat Options Oncol       Date:  2018-09-19

3.  Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT-2).

Authors:  Kristy Kummerow Broman; Tasha Hughes; Lesly Dossett; James Sun; Dennis Kirichenko; Michael J Carr; Avinash Sharma; Edmund K Bartlett; Amanda A G Nijhuis; John F Thompson; Tina J Hieken; Lisa Kottschade; Jennifer Downs; David E Gyorki; Emma Stahlie; Alexander van Akkooi; David W Ollila; Jill Frank; Yun Song; Giorgos Karakousis; Marc Moncrieff; Jenny Nobes; John Vetto; Dale Han; Jeffrey M Farma; Jeremiah L Deneve; Martin D Fleming; Matthew C Perez; Michael C Lowe; Roger Olofsson Bagge; Jan Mattsson; Ann Y Lee; Russell S Berman; Harvey Chai; Hidde M Kroon; Juri Teras; Roland M Teras; Norma E Farrow; Georgia Beasley; Jane Yuet Ching Hui; Lukas Been; Schelto Kruijff; Youngchul Kim; Syeda Mahrukh Hussnain Naqvi; Amod A Sarnaik; Vernon K Sondak; Jonathan S Zager
Journal:  Cancer       Date:  2021-04-07       Impact factor: 6.921

4.  Model Combining Tumor Molecular and Clinicopathologic Risk Factors Predicts Sentinel Lymph Node Metastasis in Primary Cutaneous Melanoma.

Authors:  Domenico Bellomo; Suzette M Arias-Mejias; Chandru Ramana; Joel B Heim; Enrica Quattrocchi; Sindhuja Sominidi-Damodaran; Alina G Bridges; Julia S Lehman; Tina J Hieken; James W Jakub; Mark R Pittelkow; David J DiCaudo; Barbara A Pockaj; Jason C Sluzevich; Mark A Cappel; Sanjay P Bagaria; Charles Perniciaro; Félicia J Tjien-Fooh; Martin H van Vliet; Jvalini Dwarkasing; Alexander Meves
Journal:  JCO Precis Oncol       Date:  2020-04-14

Review 5.  Melanoma & nuclear medicine: new insights & advances.

Authors:  Andrés Perissinotti; Daphne Dd Rietbergen; Sergi Vidal-Sicart; Ana A Riera; Renato A Valdés Olmos
Journal:  Melanoma Manag       Date:  2018-06-28

6.  The Outcome of Post-Chemotherapy Retroperitoneal Lymph Node Dissection in Patients with Metastatic Bladder Cancer in the Retroperitoneum.

Authors:  Nick W Liu; Katie S Murray; S Machele Donat; Harry W Herr; Bernard H Bochner; Guido Dalbagni
Journal:  Bladder Cancer       Date:  2019-01-31

7.  Current management of patients with melanoma who are found to be sentinel node-positive.

Authors:  Amanda A G Nijhuis; Andrew J Spillane; Jonathan R Stretch; Robyn P M Saw; Alexander M Menzies; Roger F Uren; John F Thompson; Omgo E Nieweg
Journal:  ANZ J Surg       Date:  2019-10-30       Impact factor: 1.872
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.